Johnson & Johnson vaccine ready for FDA approval
[Fox 9 News and WCCO TV News, January 29, 2021]
Johnson & Johnson announced early results that show its single-dose vaccine is effective against COVID-19, though it doesn't offer as much protection as the Pfizer and Moderna vaccines currently being used. Johnson & Johnson plans to seek an emergency use authorization from the U.S. Food and Drug Administration next week, the company said in a release. Approval could come in late February.
Dr. Frank Rhame, the Allina Health infectious disease specialist who ran J&J's Minnesota trial, said the preliminary results suggest it's far more effective than the flu shot, which Americans are encouraged to get every year.
WCCO News also reported on this story.
Share this article
